New immune combo aims to rescue ICU patients from severe pneumonia
Disease control
Not yet recruiting
This early study tests whether adding two immune-boosting treatments—nogapendekin alfa inbakicept (injections) and donor immune cells (iNKT cells)—to standard care can help critically ill adults with severe pneumonia recover. About 20 ICU patients will receive the therapy and be …
Phase: PHASE2 • Sponsor: ImmunityBio, Inc. • Aim: Disease control
Last updated Apr 26, 2026 20:03 UTC